about
Pulmonary autoimmunity as a feature of autoimmune polyendocrine syndrome type 1 and identification of KCNRG as a bronchial autoantigenAnti-SSA/Ro antibodies and the heart: more than complete congenital heart block? A review of electrocardiographic and myocardial abnormalities and of treatment optionsLupus enteritis: from clinical findings to therapeutic managementAnti-beta 2 glycoprotein I antibodies in systemic lupus erythematosus: a marker of thrombosis associated with a circulating anticoagulantImages in cardiovascular medicine. Cardiac involvement in Erdheim-Chester disease: magnetic resonance and computed tomographic scan imaging in a monocentric series of 37 patients18F-fluorodeoxyglucose-positron emission tomography scanning is more useful in followup than in the initial assessment of patients with Erdheim-Chester diseaseVariability in the efficacy of interferon-alpha in Erdheim-Chester disease by patient and site of involvement: results in eight patientsCerebral, facial, and orbital involvement in Erdheim-Chester disease: CT and MR imaging findingsImatinib mesylate for platelet-derived growth factor receptor-beta-positive Erdheim-Chester histiocytosisDramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutationErdheim-Chester disease: CT findings of thoracic involvementPulmonary involvement in Erdheim-Chester disease: a single-center study of thirty-four patients and a review of the literatureCardiovascular involvement, an overlooked feature of Erdheim-Chester disease: report of 6 new cases and a literature reviewBilateral adrenal infiltration in Erdheim-Chester disease. Report of seven cases and literature reviewCNS involvement and treatment with interferon-α are independent prognostic factors in Erdheim-Chester disease: a multicenter survival analysis of 53 patientsThe systemic capillary leak syndrome: a case series of 28 patients from a European registryReal time identification of drug-induced liver injury (DILI) through daily screening of ALT results: a prospective pilot cohort studyProceedings of Réanimation 2017, the French Intensive Care Society International CongressErdheim–Chester DiseaseInternational and multidisciplinary expert recommendations for the use of biologics in systemic lupus erythematosus.Factors influencing the efficacy of two injections of a pandemic 2009 influenza A (H1N1) nonadjuvanted vaccine in systemic lupus erythematosus.[Vitamin D and autoimmunity. First part: Fundamental aspects].Efficacy of interferon alfa-2a in severe and refractory uveitis associated with Behçet's disease.Posterior reversible encephalopathy syndrome during systemic lupus erythematosus: four new cases and review of the literature.Prominent plasmacytosis following intravenous immunoglobulin correlates with clinical improvement in Guillain-Barré syndrome.[A non-automatic diagnosis].Thrombotic thrombocytopenic purpura with severe ADAMTS-13 deficiency in two patients with primary antiphospholipid syndrome.Reactive haemophagocytic syndrome in adult-onset Still's disease: a report of six patients and a review of the literature.Systemic lupus erythematosus associated with ANCA-associated vasculitis: an overlapping syndrome?[Catastrophic antiphospholipid syndrome].Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients.[Acid sphingomyelinase deficiency (Niemann-Pick disease type B) in adulthood: A retrospective multicentric study of 28 adult cases].Clinical spectrum and therapeutic management of systemic lupus erythematosus-associated macrophage activation syndrome: A study of 103 episodes in 89 adult patients.Anticardiolipin, anti-beta2-glycoprotein I, and antinucleosome antibodies in hepatitis C virus infection and mixed cryoglobulinemia. Multivirc Group.The key role of nucleosomes in lupus.[Small fibre neuropathy: Diagnostic approach and therapeutic issues, and its association with primary Sjögren's syndrome].[Central nervous system involvement in systemic diseases: Spectrum of MRI findings].Correlation of anti-signal recognition particle autoantibody levels with creatine kinase activity in patients with necrotizing myopathy.The role of nucleosomes in lupus.Exhausted cytotoxic control of Epstein-Barr virus in human lupus.
P50
Q24647314-EE4B27B6-5B2A-4952-B490-2013B8619EA6Q24804359-B019C159-4E5B-4F41-8418-23C5FE10D021Q26829733-F155A5FA-7A87-46EC-8379-F735898D443DQ28247208-5CB65BCA-17B5-40F6-9C33-3490BDFDE173Q28250348-95EF2F6E-BC78-48A5-BD10-C56D4C0806D4Q28259927-5F8D870F-21A4-4B2A-9988-99ED92DF5CAFQ28266050-2BF79D91-0BA1-4711-8BAF-726C2F035DEDQ28280433-A1561A07-8C34-4177-AA77-309DD9E4DA66Q28281443-12BF6F38-7D0A-437C-9235-071953A0B0FFQ28281888-C516F3D5-4174-4393-99FF-D0DF6D6BC729Q28285766-2415A837-BD61-4F7F-AFE2-2D263C4B6A71Q28288917-9EA56E6A-6C73-4AD0-B50C-B569A1E9F680Q28291620-B50AEC8F-85C8-4736-83F1-0B4F6ACD7257Q28296312-68F06BDC-D7C3-4BBC-928C-8EEC434F6D86Q28303400-882C40C0-3BA5-4E7E-A3A8-3F915492FF17Q28308214-EAFD6457-6819-4136-9CE2-FE737836123DQ28482250-BC79FF8A-D16D-4B48-B8F9-FB459CA00BCAQ28564101-94DFBE95-5A5F-4290-A1A3-48DB1D5CEC66Q30047444-3DB9726C-3C7A-4972-A636-F6394F12F16CQ30234696-CD6CFD44-75C9-464C-9ED0-6454D274E466Q30405609-2035D07C-E61E-4A9A-A0D9-CB6E7CC44325Q30411161-3B1A6B54-BF45-43D1-BBBA-8F392DEB063EQ30659915-DEF4982C-637F-4E47-8E5C-1C1F6DD2536BQ31145483-7843C165-65C6-4CDA-B5CF-8F68E8650454Q33332176-CC40A2F6-3A42-4A22-8DA7-80E63A664747Q33343142-7EFE1E48-7BDE-4CCB-9CB3-FAE7145C9F6DQ33363176-05E80402-6C2D-4DC0-B742-FCE5CD44BFC2Q33370577-823E6E6E-6ADD-47B9-B303-A149D9C1E12FQ33396447-87DCF4E9-1544-4217-A155-40AEBB7E4BCCQ33399770-D28057AB-1638-4AF9-B991-258BCA8FA9FAQ33412915-18DF84BA-A466-4971-AEC7-F34BAC1E814BQ33437063-E2DAF2BC-524C-45D6-A42F-F22818AC4A05Q33441685-9B0CEDDF-CBB1-40A1-A106-EBE4C367512EQ33500894-93B2D023-D8FB-4F0D-AB93-98E1D448E903Q33633300-F710D8F7-69AD-4927-A221-9B0D09B12F17Q33695536-F77F6837-5EB9-4AA2-A977-82840EABC91AQ33720414-00A65827-7840-4D4C-9549-737AF8140E79Q33844947-AD2EF654-1C25-4390-A41A-B05D5CDED6BEQ34035086-2A3B8C83-BF81-446F-82D6-F1643D055CE8Q34058156-EEA9C041-62C7-46F8-B2AA-F813452799C4
P50
name
Zahir Amoura
@ast
Zahir Amoura
@en
Zahir Amoura
@nl
type
label
Zahir Amoura
@ast
Zahir Amoura
@en
Zahir Amoura
@nl
prefLabel
Zahir Amoura
@ast
Zahir Amoura
@en
Zahir Amoura
@nl
P214
P214
P31
P7859
viaf-172717820